WuXi Biologics’ revenue jumps in H1 2026 as it accelerates capacity expansion

Thursday, August 27, 2026 (Greg Slabodkin)View original

The Chinese CRDMO is boosting manufacturing capacity globally through continued investments in China, Singapore, and the United States.

Read the full article on the original site.